Online Inquiry
EGFR (L65V/+/+) Cell Line
SPL-01234
| Size | Price |
| 1 Unit | Online Inquiry |
| Description |
|---|
| EGFR (L65V/+/+) |
| Target Information | |
|---|---|
| Target Name | EGFR |
| Gene Abbr. | EGFR |
| Gene ID | 1956 |
| Full Name | epidermal growth factor receptor |
| Alias | ERBB, ERBB1, HER1, NISBD2, PIG61 |
| Species | Human |
| Genomic Locus | 7p12 |
| Introduction | The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. [provided by RefSeq, Jun 2016]. |
| Product Details | |
|---|---|
| Cell Line Model | SW48 |
| Genotype | EGFR (L65V/+/+) |
| Description | EGFR (L65V/+/+) |
| Parental ATCC ID | CCL-231 |
| STR Profile | Amelogenin: X; CSF1PO: 9,10; D13S317: 11, 12; D16S539: 11,13; D5S818: 10, 14; D7S820: 9, 10; THO1: 6,9.3; TPOX: 8; vWA: 18,20, 21; ATCC |
| Disease | Colorectal adenocarcinoma, Dukes Type C Grade IV |
| Tissue | Colon |
| Gender | Female |
| Key Endogenous Mutations | CTNNB1, FBXW7, EGFR |
| CVT Selection Condition | G418 resistant - 0.8 mg/mL |
| Cell Number | 2x10^6 |
| Handling Specifications | |
|---|---|
| Revival | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. Split at 70-80% confluency, approximately 1:3-1:6. Cells may experience a lag period of approximately 1 week before stable growth is achieved. |
| Culture Medium | RPMI 1640 including 2 mM L-glutamine and 25 mM sodium bicarbonate, supplemented with 10% FBS. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. Split at 70-80% confluency, approximately 1:3-1:6. Cells may experience a lag period of approximately 1 week before stable growth is achieved. |
| Freeze Medium | Complete growth media 45% + USDA approved FBS 50% + DMSO 5% |
| Biosafety Level | BSL-1 |
| Disclaimer | This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations. |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.